Gregory Russotti

Directeur Technique/Scientifique/R&D chez CENTURY THERAPEUTICS, INC.

Fortune : 1 M $ au 31/05/2024

57 ans

Health Technology

Consumer Services

Finance

Postes actifs de Gregory Russotti

Sociétés	Poste	Début	Fin
CENTURY THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	01/01/2020	-
	Directeur Général	11/04/2023	04/12/2023
	President	11/04/2023	04/12/2023
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Consultant / Advisor	-	-

Sociétés	Poste	Début	Fin
CELGENE	Corporate Officer/Principal	01/10/2017	31/12/2019

Rensselaer Polytechnic Institute	Graduate Degree
Rutgers State University of New Jersey	Doctorate Degree

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
CENTURY THERAPEUTICS, INC.	Health Technology

Entreprise privées	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Finance

Entreprise privées

Health Technology

Finance